News & Updates

Wearable device improves fatigue, life quality in SSc patients

15 Mar 2025 by

Use of the Apollo wearable for 1 month leads to improvements in fatigue and Raynaud phenomenon (RP) symptoms in patients with systemic sclerosis (SSc), according to a pilot study.

Wearable device improves fatigue, life quality in SSc patients

15 Mar 2025

Abnormal uterine bleeding during menopause transition linked to fatigue

15 Mar 2025

Women experiencing heavy or prolonged menstrual bleeding during the menopause transition appear to be predisposed to fatigue, according to a study.

Abnormal uterine bleeding during menopause transition linked to fatigue

15 Mar 2025

Ruxolitinib cream shows benefit in patients with AD regardless of age

15 Mar 2025 by

Twice-daily application of ruxolitinib cream appears effective and well tolerated in the treatment of mild-to-moderate atopic dermatitis (AD) regardless of age, based on a pooled analysis of three phase III trials presented at AAAAI/WAO 2025.

Ruxolitinib cream shows benefit in patients with AD regardless of age

15 Mar 2025

Social vulnerability implicated in urinary incontinence burden in women

14 Mar 2025

Women who are socially vulnerable appear to have worse urinary incontinence and poorer incontinence-related quality of life, according to a study.

Social vulnerability implicated in urinary incontinence burden in women

14 Mar 2025

High-dose vitamin D may quell clinically isolated syndrome of MS

14 Mar 2025 by

Supplementation with high-dose vitamin D in patients with clinically isolated syndrome typical for multiple sclerosis (MS) helps lower disease activity, as shown in the D-Lay MS trial.

High-dose vitamin D may quell clinically isolated syndrome of MS

14 Mar 2025

Ureteral stent omission safe, feasible in RARC-IC

14 Mar 2025

A recent study has shown the safety and feasibility of omitting ureteral stent placement during robot-assisted radical cystectomy with intracorporeal ileal conduit (RARC-IC).

Ureteral stent omission safe, feasible in RARC-IC

14 Mar 2025

Twice-yearly depemokimab safe, effective in CRSwNP

14 Mar 2025 by

Treatment with two doses of depemokimab results in sufficient concentrations to adequately control blood eosinophil counts (BEC) over 1 year, as shown in the ANCHOR 1 and 2 trials. This finding suggests sustained anti-interleukin-5 (IL-5) biological effect and impact on type 2 inflammation.

Twice-yearly depemokimab safe, effective in CRSwNP

14 Mar 2025

TXA use in radical cystectomy reduces bleeding, need for blood transfusion

14 Mar 2025

Using tranexamic acid (TXA) appears to lessen blood loss and the need for perioperative blood transfusion (PBT) without increasing the risk of venous thromboembolism (VTE) in patients with bladder cancer undergoing radical cystectomy, reports a study.

TXA use in radical cystectomy reduces bleeding, need for blood transfusion

14 Mar 2025

Omalizumab continues to OUtMATCH OIT in updated analysis

14 Mar 2025 by

Omalizumab remains superior to oral immunotherapy (OIT) for the treatment of multi-food allergies with fewer adverse effects in Stage 2 of the NIH*-sponsored phase III OUtMATCH** study, the first head-to-head trial comparing the two treatments.

Omalizumab continues to OUtMATCH OIT in updated analysis

14 Mar 2025

H56:IC31 vaccine of no help against TB recurrence

14 Mar 2025

For individuals who completed treatment for pulmonary tuberculosis (TB), vaccination with H56:IC31 does not appear to reduce the risk of disease recurrence, according to a phase 2b trial.

H56:IC31 vaccine of no help against TB recurrence

14 Mar 2025

News & Updates

Filter by Specialty:

Specialty:

Wearable device improves fatigue, life quality in SSc patients

Wearable device improves fatigue, life quality in SSc patients

Abnormal uterine bleeding during menopause transition linked to fatigue

Abnormal uterine bleeding during menopause transition linked to fatigue

Ruxolitinib cream shows benefit in patients with AD regardless of age

Ruxolitinib cream shows benefit in patients with AD regardless of age

Social vulnerability implicated in urinary incontinence burden in women

Social vulnerability implicated in urinary incontinence burden in women

High-dose vitamin D may quell clinically isolated syndrome of MS

High-dose vitamin D may quell clinically isolated syndrome of MS

Ureteral stent omission safe, feasible in RARC-IC

Ureteral stent omission safe, feasible in RARC-IC

Twice-yearly depemokimab safe, effective in CRSwNP

Twice-yearly depemokimab safe, effective in CRSwNP

TXA use in radical cystectomy reduces bleeding, need for blood transfusion

TXA use in radical cystectomy reduces bleeding, need for blood transfusion

Omalizumab continues to OUtMATCH OIT in updated analysis

Omalizumab continues to OUtMATCH OIT in updated analysis

H56:IC31 vaccine of no help against TB recurrence

H56:IC31 vaccine of no help against TB recurrence